reviewTop 1% cited
ESC/EAS Guidelines for the management of dyslipidaemias
Atherosclerosis · 2011 · Vol. 217(1) · pp. 3–46
Citations
704
FWCI
76.04
field-weighted impact
References
442
Percentile
100%
vs. same field & year
Citations per year
Cited by
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Nutrients · 2013 · 1,637 citations
References
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
The Lancet · 2002 · 6,993 citations
Exercise for overweight or obesity
Cochrane Database of Systematic Reviews · 2006 · 943 citations
Interventions for enhancing medication adherence
Cochrane Database of Systematic Reviews · 2014 · 2,950 citations
Statins for the primary prevention of cardiovascular disease
Cochrane Database of Systematic Reviews · 2013 · 1,829 citations
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study
Diabetologia · 2001 · 1,118 citations
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
European Heart Journal · 2011 · 3,538 citations
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Diabetologia · 2003 · 723 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
